Academic and commercial researchers will be able to apply to use samples and/or data from the UK ME/CFS Biobank if they present a sound scientific rationale for the proposed study and have a good research track record. Eligible researchers must be supported by their institution.
All research proposals intending to use samples from the UK ME/CFS Biobank must be developed in line with the Biobank’s mission; proposals intending to develop the following types of studies will be prioritised:
Over 500 participants have been included in this study. ME/CFS participants have been diagnosed by physicians and are compliant with CDC ’94 (Fukuda) and/or Canadian Consensus Criteria (CCC); case definition compliance are available for four other commonly-used criteria. Samples are available from four groups of participants: